Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月

How to Use Pepsin

Continue reading
06 2 月

New Antibody Release // FoxP3: A Rising Star in Tumor Immunity and Prognostic Markers

Continue reading
06 2 月

IHC Technique Guide: A Brief Introduction to Secondary Antibodies

Continue reading
06 2 月

Experience Market Dynamics, Strategize Marketing Plans—Company Holds 2014 Annual Marketing Discussion Meeting

Continue reading
06 2 月

Uniting the Nine, Advancing Together with Mai

Continue reading
06 2 月

In the Era of Precision Medicine, the Importance of Pathological Diagnosis is Highlighted—Latest “Clinical Rational Use Management Indicators for Antitumor Drugs” Released

Continue reading
06 2 月

Cytokeratin Subtypes and Their Expression in Normal Cells

Continue reading
06 2 月

Chinese Research Hospital Association Establishes Pathology Professional Committee in Urumqi

Continue reading
06 2 月

Young and Old Gather Together to Welcome the 20th Anniversary of Maixin

Continue reading
06 2 月

Pathology Conference Fosters Development, Hefei Gathering Strengthens Bonds

Continue reading
  • «
  • ‹
  • 43
  • 44
  • 45
  • 46
  • 47
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar